Browse Title Index


 
Issue Title
 
Vol 18, No 2 (2011) Rash rates with EGFR inhibitors: meta-analysis Abstract   PDF   HTML
N. Mittmann, S. J. Seung
 
Vol 24, No 1 (2017) Rate of EGFR mutation testing for patients with non-squamous non-small cell lung cancer with implementation of reflex testing by pathologists Abstract   PDF   HTML
P. K. Cheema, S. Raphael, R. El-Maraghi, J. Li, R. McClure, L. Zibdawi, A. Chan, J.C. Victor, A. Dolley, A. Dziarmaga
 
Vol 25, No 3 (2018) Rates of cannabis use in patients with cancer Abstract   PDF   HTML   SUPPLEMENTAL MATERIAL
K. Martell, A. Fairchild, B. LeGerrier, R. Sinha, S. Baker, H. Liu, A. Ghose, I.A. Olivotto, M. Kerba
 
Vol 17, No 6 (2010) Re. Consent to external-beam radiotherapy Details   PDF
D. Benatar
 
Vol 17, No 6 (2010) Re. Multimodality breast cancer screening in women with a familial or genetic predisposition Details   PDF
S.A. Narod
 
Vol 21, No 5 (2014) re: Reflections on screening mammography and the early detection of breast cancer Abstract   PDF   HTML
M. Baum
 
Vol 22, No 6 (2015) Reactivation of hepatitis B virus after withdrawal of erlotinib Abstract   PDF   HTML
N. Bui, I. Wong-Sefidan
 
Vol 22, No 4 (2015) Ready or not? Lung cancer diagnosis in 2015 Abstract   PDF   HTML
K. Jao, C. Labbe, N.B. Leighl
 
Vol 24, No 4 (2017) Real-life treatment of metastatic colorectal cancer with regorafenib: a single-centre review Abstract   PDF   HTML
J. Gotfrit, M. Vickers, S. Sud, T. Asmis, C. Cripps, R. Goel, T. Hsu, D. Jonker, R. Goodwin
 
Vol 23, No 3 (2016) Real-world adjuvant TAC or FEC-D for HER2-negative node-positive breast cancer in women less than 50 years of age Abstract   PDF   HTML
S. Lupichuk, D. Tilley, X. Kostaras, A.A. Joy
 
Vol 25, No 6 (2018) Real-world benefit of nivolumab in a Canadian non-small-cell lung cancer cohort Abstract   PDF   HTML
R. A. Juergens, C. Mariano, J. Jolivet, N. Finn, J. Rothenstein, M. N. Reaume, A. Faghih, C. Labbé, S. Owen, F. A Shepherd, J. Villeneuve, F. Romeyer, F. Pettersson, C. Butts
 
Vol 26, No 2 (2019) Real-world costing analysis for diffuse large B-cell lymphoma in British Columbia Abstract   PDF   HTML
S. Costa, D. W. Scott, C. Steidl, S. J. Peacock, D. A. Regier
 
Vol 18, No 3 (2011) Real-world experience with adjuvant FEC-D chemotherapy in four Ontario regional cancer centres Abstract   PDF   HTML
Y. Madarnas, S. F. Dent, S. F. Husain, A. Robinson, S. Alkhayyat, W. M. Hopman, J. Verreault, T. Vandenberg
 
Vol 20, No 3 (2013) Real-world impact of granulocyte-colony stimulating factor on febrile neutropenia Abstract   PDF   HTML
A.K. Altwairgi, W.M. Hopman, M. Mates
 
Vol 25, No 1 (2018) Real-world outcomes in patients with ALK-positive non-small cell lung cancer treated with crizotinib Abstract   PDF   HTML
K.L. Davis, J.A. Kaye, E.T. Masters, S. Iyer
 
Vol 26, No 2 (2019) Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium Abstract   PDF   HTML
I. Stukalin, J. C. Wells, J. Graham, T. Yuasa, B. Beuselinck, C. Kollmansberger, D. S. Ernst, N. Agarwal, T. Le, F. Donskov, A. R. Hansen, G. A. Bjarnason, S. Srinivas, L. A. Wood, A. S. Alva, R. Kanesvaran, S. Y. F. Fu, I. D. Davis, T. K. Choueiri, D.Y.C. Heng
 
Vol 25, No 4 (2018) Real-world patient- and caregiver-reported outcomes in advanced breast cancer Abstract   PDF   Supplemental Material   HTML
V. Lambert-Obry, A. Gouault-Laliberté, A. Castonguay, G. Zanotti, T. Tran, M. Mates, J. Lemieux, P. Chabot, C. Prady, F. Couture, J. Lachaine
 
Vol 26, No 2 (2019) Real-world systemic therapy treatment patterns for squamous cell carcinoma of the head and neck in Canada Abstract   PDF   HTML
K. Byrne, P. Hallworth, A. Abbas Tahami Monfared, A. Moshyk, J. W. Shaw
 
Vol 24, No 6 (2017) Reasons for lack of referral to medical oncology for systemic therapy in stage IV non-small-cell lung cancer: comparison of 2003–2006 with 2010–2011 Abstract   PDF   HTML
J.J. Ko, R. Tudor, H. Li, M. Liu, K. Skolnik, W. Kells Boland, J. Macklow, D. Morris, D.G. Bebb
 
Vol 22, No 6 (2015) Reasons for palliative treatments in stage III non-small-cell lung cancer: what contribution is made by time-dependent changes in tumour or patient status? Abstract   PDF   HTML
A.G. Robinson, K. Young, K. Balchin, T. Owen, A. Ashworth
 
Vol 13, No 5 (2006) Recent Advances In Adjuvant Systemic Treatment for Breast Cancer: All Systems Go! Details   PDF
Sunil Verma
 
Vol 14, No 2 (2007) Recent Advances in Tumor Biology of the GPI-Anchored Carcinoembryonic Antigen Family Members CEACAM5 and CEACAM6 Details   PDF
Cliff Stanners, Carlos H. F. Chan
 
Vol 22, No 4 (2015) Recent trends in breast, cervical and colorectal cancer screening test utilization in Canada, using self-reported data from 2008 and 2012 Abstract   PDF   HTML
D. Major, D. Armstrong, H. Bryant, W. Cheung, K. Decker, G. Doyle, V. Mai, C.M. McLachlin, J. Niu, J. Payne, N. Shukla
 
Vol 19, No 3 (2012) Recently published indicators allow for comparison of radiation treatment rates relative to evidence-based guidelines for rectal cancer Abstract   PDF   HTML
R. Rahal, T. Forte, G. Lockwood, J. Klein- Geltink, H. Bryant
 
Vol 13, No 5 (2006) Receptor Tyrosine Kinases: Role in Cancer Progression Details   PDF
Morag Park, Veena Sangwan
 
Vol 21, No 5 (2014) Recommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada? Abstract   PDF   HTML
S. Patel, X. Kostaras, M. Parliament, I.A. Olivotto, R. Nordal, K. Aronyk, N. Hagen
 
Vol 13, No 6 (2006) Recommendations of the Canadian Consensus Group on the Management of Chronic Myeloid Leukemia Abstract   PDF
Pierre Laneuville, Michael Jeremy Barnett, Robert Belanger, Stephen Couban, Donna Lynn Forrest, Denis-Claude Roy, Jeffrey Howard Lipton
 
Vol 23, No 6 (2016) Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies Abstract   PDF   HTML   Supplemental Material
J. Gagnon, E. Lévesque, the Clinical Advisory Committee on Breast Cancer Screening and Prevention (F. Borduas, J. Chiquette, C. Diorio, N. Duchesne, M. Dumais, L. Eloy, W. Foulkes, N. Gervais, L. Lalonde, B. L’Espérance, S. Meterissian, L. Provencher, J. Richard, C. Savard, I. Trop, N. Wong), B.M. Knoppers, J. Simard
 
Vol 26, No 4 (2019) Reconsidering the turnaround times for BRAF V600 mutation analysis in non-small-cell lung cancer: a molecular diagnosis in one day is achievable for rapid treatment choices Abstract   PDF   HTML
A. Uguen
 
Vol 22, No 1 (2015) Rectal cancer resection and circumferential margin rates in Canada: a population-based study Abstract   PDF   HTML
K. DeCaria, R. Rahal, J. Niu, G. Lockwood, H. Bryant
 
Vol 20, No 5 (2013) Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge Abstract   PDF   HTML
Tao Xu, J. Tang, M. Gu, L. Liu, W. Wei, H. Yang
 
Vol 21, No 1 (2014) Reduced expression of members of the MHC-I antigen processing machinery in ethnic Uighur women with cervical cancer in the Xinjiang region of China Abstract   PDF   HTML
A. Haimiti, Y. Hailiman, A. Gulina, J. Du, Z. Hao, X.L. Rong, A. Zainuer, W. Qin, S. Lalai
 
Vol 25, No 6 (2018) Reducing postsurgical exudate in breast cancer patients by using San Huang decoction to ameliorate inflammatory status: a prospective clinical trial Abstract   PDF   Supplemental Material   HTML
Z. Y. Zhu, J. X. Xue, L. X. Yu, W. H. Bian, Y. F. Zhang, K. C. Sohn, I. H. Shin, C. Yao
 
Vol 23, No 3 (2016) Reduction in membranous immunohistochemical staining for the intracellular domain of epithelial cell adhesion molecule correlates with poor patient outcome in primary colorectal adenocarcinoma Abstract   PDF   HTML
A. Wang, R. Ramjeesingh, C.H. Chen, D. Hurlbut, N. Hammad, L.M. Mulligan, C. Nicol, H.E. Feilotter, S. Davey
 
Vol 21, No 4 (2014) Reflecting on inpatient palliative chemotherapy— is there ever a “right place” at the “right time”? Abstract   PDF   HTML
D. Rayson, D.A. Kain
 
Vol 21, No 5 (2014) Reflections on screening mammography and the early detection of breast cancer Abstract   PDF   HTML
S.A. Narod
 
Vol 25, No 1 (2018) Regional process redesign of lung cancer care: a learning health system pilot project Abstract   PDF   HTML
M. Fung-Kee-Fung, D.E. Maziak, J.R. Pantarotto, J. Smylie, L. Taylor, T. Timlin, T. Cacciotti, P.J. Villeneuve, C. Dennie, C. Bornais, S. Madore, J. Aquino, P. Wheatley-Price, R.S. Ozer, D.J. Stewart
 
Vol 23, No 4 (2016) Regional variation in the management of metastatic gastric cancer in Ontario Abstract   PDF   HTML
A.L. Mahar, N.G. Coburn, D.J. Kagedan, R. Viola, A.P. Johnson
 
Vol 16, No 4 (2009) Regression of follicular lymphoma with Devil’s Claw; coincidence or causation? Abstract   PDF
Kenneth Scott Wilson
 
Vol 24, No 3 (2017) Rehabilitation and exercise oncology program: translating research into a model of care Abstract   PDF   HTML
M.A. Dalzell, N. Smirnow, W. Sateren, A. Sintharaphone, M. Ibrahim, L. Mastroianni, L.D. Vales Zambrano, S. O'Brien
 
Vol 17, No 3 (2010) Re-irradiation of metastatic disease in the neck from xeroderma pigmentosum Abstract   PDF
C. C. Wei, N. J. Sanfilippo, D. J. Myssiorek
 
Vol 23, No 1 (2016) Relationship between HLA-DRB1 allele polymorphisms and familial aggregations of hepatocellular carcinoma Abstract   PDF   HTML
S. Ma, J. Wu, J. Wu, Y. Wei, L. Zhang, Q. Ning, D. Hu
 
Vol 22, No 3 (2015) Relationship between progression-free survival and overall survival in chronic lymphocytic leukemia: a literature-based analysis Abstract   PDF   HTML
C. Beauchemin, J.B. Johnston, M.È. Lapierre, F. Aissa, J. Lachaine
 
Vol 21, No 6 (2014) Relationship of thyroid transcription factor 1 to EGFR status in non-small-cell lung cancer Abstract   PDF   HTML
B.S. Sheffield, I.E. Bosdet, R.H. Ali, S.S. Young, B.K. McNeil, C. Wong, K. Dastur, A. Karsan, D.N. Ionescu
 
Vol 22, No 4 (2015) Relationships between patient knowledge and the severity of side effects, daily nutrient intake, psychological status, and performance status in lung cancer patients Abstract   PDF   HTML
J. Tian, L.N Jia, Z.C. Cheng
 
Vol 16, No 6 (2009) Relative dose intensity delivered to patients with early breast cancer: Canadian experience Abstract   PDF
J. Younus, S. Raza, S. Welch
 
Vol 21, No 2 (2014) Remembrance day Abstract   PDF   HTML
A.C. Swan
 
Vol 26, No 3 (2019) Renal cell carcinoma in the Canadian Indigenous population Abstract   PDF   HTML
E. C. L. Wong, R. H. Breau, R. Mallick, L. Wood, F. Pouliot, N. S. Basappa, S. Tanguay, D. Soulières, A. So, D. Heng, L. T. Lavallee, D. Drachenberg, A. Kapoor
 
Vol 23, No 5 (2016) Reoperation costs in attempted breast-conserving surgery: a decision analysis Abstract   PDF   HTML
R. Pataky, C.R. Baliski
 
Vol 17, No 2 (2010) Reply from Dr. Luis Souhami Details   PDF
L. Souhami
 
Vol 17, No 3 (2010) Reply from Drs. Luis Souhami and Fabio Cury Abstract   PDF
L. Souhami, F. Cury
 
Vol 19, No 6 (2012) Report from the 13th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Calgary, Alberta; September 8–10, 2011 Abstract   PDF   HTML
M.M. Vickers, J. Pasieka, E. Dixon, S. McEwan, A. McKay, D. Renouf, D. Schellenberg, D. Ruether
 
Vol 23, No 6 (2016) Report from the 17th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Edmonton, Alberta; 11–12 September 2015 Abstract   PDF   HTML
K.E. Mulder, S. Ahmed, J. Davies, C.M. Doll, S. Dowden, S. Gill, V. Gordon, P. Hebbard, H. Lim, A. McFadden, J.P. McGhie, J. Park, R. Wong
 
Vol 25, No 4 (2018) Report from the 19th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Winnipeg, Manitoba; 29–30 September 2017 Abstract   PDF   HTML
C.A. Kim, S. Ahmed, S. Ahmed, B. Brunet, H. Chalchal, R. Deobald, C. Doll, M.P. Dupre, V. Gordon, R.M. Lee-Ying, H. Lim, D. Liu, J. Loree, J.P. McGhie, K. Mulder, J. Park, B. Yip, R.P. Wong, A. Zaida, on behalf of the Western Canadian Gastrointestinal Cancer Group
 
Vol 23, No 2 (2016) Report on a Delphi process and workshop to improve accrual to cancer clinical trials Abstract   PDF   HTML
J.A.H. Bell, L.G. Balneaves, M.T. Kelly, H. Richardson
 
Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective RESEARCH AND REGULATORY ISSUES FOR INTEGRATIVE ONCOLOGY Abstract   PDF
Stephen Sagar, Raimond K.W. Wong
 
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective Research in castration-resistant prostate cancer: what does the future hold? Abstract   PDF
R. J. Macfarlane, K. N. Chi
 
Vol 23, No 2 (2016) Research output and the public health burden of cancer: is there any relationship? Abstract   PDF   HTML
F.M. Patafio, S.C. Brooks, X. Wei, Y. Peng, J. Biagi, C.M. Booth
 
Vol 26, No 3 (2019) Research priorities for the pan-Canadian Oncology Symptom Triage and Remote Support practice guides: a modified nominal group consensus Abstract   PDF   HTML
L. A. Jibb, D. Stacey, M. Carley, A. Davis, I. D. Graham, E. Green, L. Jolicoeur, C. Kuziemsky, C. Ludwig, T. Truant, The COSTaRS Team
 
Vol 15, No 6 (2008) Residual cancer burden in locally advanced breast cancer: a superior tool Abstract   PDF
Zeina Ahmad Nahleh
 
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Resistance to epidermal growth factor receptor tyrosine kinase inhibitors, T790M, and clinical trials Abstract   PDF   HTML
G.M. O’Kane, T.A. Barnes, N.B. Leighl
 
Vol 16, No 5 (2009) Resolution of severe oncogenic hypophosphatemic osteomalacia after resection of a deeply located soft tissue tumour Details   PDF
M.K. Nusier, A.R.M. Radaideh, D. Jaradat, M.M. Abu-Kalaf,
 
Vol 26, No 4 (2019) Resource use in the last three months of life by lung cancer patients in southern Ontario Abstract   PDF   HTML
Y. Wang, A. Van Dam, M. Slaven, K. J. Ellis, J. R. Goffin, R. A. Juergens, P. M. Ellis
 
Vol 24, No 3 (2017) Resource utilization and costs of managing patients with advanced melanoma: a Canadian population-based study Abstract   PDF   HTML
F. Gwadry-Sridhar, S. Nikan, A. Hamou, S.J. Seung, T. Petrella, A.M. Joshua, S. Ernst, N. Mittmann
 
Vol 16, No 5 (2009) Response to 5-fluorouracil in metastatic extramammary Paget disease of the scrotum presenting as pancytopenia and back pain Details   PDF
K.M. Beleznay, M.A. Levesque, S. Gill
 
Vol 20, No 3 (2013) Response to Bernardi and colleagues Abstract   PDF   HTML
M. Tehfe
 
Vol 19, No 1 (2012) Response to second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer: make no assumptions Abstract   PDF   HTML
I. Karam, B. Melosky
 
Vol 20, No 6 (2013) Response to “Adenocarcinoma not otherwise specified or cribriform adenocarcinoma on dorsum of tongue?” Abstract   PDF   HTML
V. Venkatesan
 
Vol 21, No 6 (2014) Response to “Need to minimize bias when surveying patient attitudes to stopping cml treatment” Abstract   PDF   HTML
D. Sanford, R. Kyle, A. Lazo–Langner, A. Xenocostas, I. Chin–Yee, K. Howson–Jan, C.C. Hsia
 
Vol 23, No 2 (2016) Response to: Second-line treatment of non-small-cell lung cancer with wild-type EGFR status. What is the best approach? Abstract   PDF   HTML
K.A. Ma, G. Kasymjanova, V. Cohen, J. Agulnik
 
Vol 19, No 6 (2012) Response to: What is the optimal management of dysphagia in metastatic esophageal cancer? Details   PDF   HTML
W.C. Hanna, L. Ferri
 
Vol 22, No 5 (2015) Response to: “Beyond the mammography debate: a moderate perspective” Abstract   PDF   HTML
M.J. Yaffe
 
Vol 22, No 5 (2015) Response to: “Counterpoint re: ‘Mammography screening—sticking to the science’” Abstract   PDF   HTML
M.J. Yaffe
 
Vol 22, No 5 (2015) Response to: “Current definition of locally advanced breast cancer” Abstract   PDF   HTML
M. Brackstone
 
Vol 23, No 3 (2016) Response to: “Small-cell carcinoma of the genitourinary tract: a point of view” Abstract   PDF   HTML
N. Pervez
 
Vol 23, No 3 (2016) Response to: “[Miller’s] Response to: ‘Beyond the mammography debate: a moderate perspective’” Abstract   PDF   HTML
M.J. Yaffe
 
Vol 23, No 3 (2016) Response to: “[Yaffe’s] Response to: ‘Beyond the mammography debate: a moderate perspective’” Abstract   PDF   HTML
A.B. Miller
 
Vol 20, No 3 (2013) Responses by breast and prostate cancer patients to out-of-pocket costs in Newfoundland and Labrador Abstract   PDF   HTML
E. Housser, M. Mathews, J. LeMessurier, S. Young, J. Hawboldt, R. West
 
Vol 13, No 6 (2006) Retinoids, Vitamin D, Invasion, and Metastasis Details   PDF
Richard J Ablin, Erik J. Tokar, Mukta M. Webber
 
Vol 23, No 3 (2016) Retrospective analysis of the effect of CAPOX and mFOLFOX6 dose intensity on survival in colorectal patients in the adjuvant setting Abstract   PDF   HTML
A. Mamo, J. Easaw, F. Ibnshamsah, A. Baig, Y.S. Rho, T. Kavan, G. Batist, P. Kavan
 
Vol 15, No 6 (2008) RETROSPECTIVE PRACTICE REVIEW OF METASTATIC NON-SMALL CELL LUNG CANCER TREATMENT WITH SECOND-LINE ERLOTINIB Abstract   PDF
Barbara Melosky, Jason Agulnik, Hazem Assi
 
Vol 22, No 4 (2015) Revealing a cancer diagnosis to patients: attitudes of patients, families, friends, nurses, and physicians in Lebanon—results of a cross-sectional study Abstract   PDF   HTML
F. Farhat, A. Othman, G. el Baba, J. Kattan
 
Vol 26, No 2 (2019) Review of Bruton tyrosine kinase inhibitors for the treatment of relapsed or refractory mantle cell lymphoma Abstract   PDF   HTML   Supplemental Material
C. Owen, N. L. Berinstein, A. Christofides, L. H. Sehn
 
Vol 16 (2009): Renal Cell Carcinoma Supplement Review of guidelines on the treatment of metastatic renal cell carcinoma Abstract   PDF
Denis Soulieres
 
Vol 19, No 4 (2012) Right atrial metastasis of uterine leiomyosarcoma causing obstructive shock Abstract   PDF   HTML
S. K. A. Nguyen, F. Wong
 
Vol 24, No 2 (2017) Rising rates of colorectal cancer among younger Iranians: is diet to blame? Abstract   PDF   HTML
S. Hessami Arani, M.A. Kerachian
 
Vol 24, No 6 (2017) Risk and predictors of suicide in colorectal cancer patients: a Surveillance, Epidemiology, and End Results analysis Abstract   PDF   HTML
H.H. Samawi, A.A. Shaheen, P.A. Tang, D.Y.C. Heng, W.Y. Cheung, M.M. Vickers
 
Vol 26, No 2 (2019) Risk factors and a predictive nomogram for non-sentinel lymph node metastases in Chinese breast cancer patients with one or two sentinel lymph node macrometastases and mastectomy Abstract   PDF   HTML
X. Y. Wang, J. T. Wang, T. Guo, X. Y. Kong, L. Chen, J. Zhai, Y. Q. Gao, Y. Fang, J. Wang
 
Vol 19, No 3 (2012) Risk factors and early detection of breast cancer: facts, questions, and genome-based perspectives Details   PDF   HTML
D. E. Ziogas
 
Vol 21, No 5 (2014) Risk factors for locoregional recurrence after postmastectomy radiotherapy in breast cancer patients with four or more positive axillary lymph nodes Abstract   PDF   HTML
Q. Li, S. Wu, J. Zhou, J. Sun, F. Li, Q. Lin, X. Guan, H. Lin, Z. He
 
Vol 22, No 6 (2015) Risk perception and psychological morbidity in men at elevated risk for prostate cancer Abstract   PDF   HTML
A.G. Matthew, T. Davidson, S. Ochs, K.L. Currie, A. Petrella, A. Finelli
 
Vol 23, No 6 (2016) Risk stratification, treatment selection, and transplant eligibility in multiple myeloma: a qualitative study of the perspectives and self-reported practices of oncologists Abstract   PDF   HTML
T.W. LeBlanc, A. Howson, W. Turell, P. Sheldon, S.C. Locke, S.A. Tuchman, C. Gasparetto, S. Kaura, Z.M. Khan, A.P. Abernethy
 
Vol 16, No 4 (2009) RNAi and microRNA-oriented therapy in cancer: rationales, promises and challenges Details   PDF
Thomas Duchaine, Frank Slack
 
Vol 16 (2009): Renal Cell Carcinoma Supplement Role of cytokine therapy for Renal Cell Carcinoma in the era of targeted agents Abstract   PDF
Sebastien J. Hotte, Rama Koneru
 
Vol 20, No 2 (2013) Role of endolaryngeal surgery (with or without laser) compared with radiotherapy in the management of early (T1) glottic cancer: a clinical practice guideline Abstract   PDF   HTML
J. Yoo, C. Lacchetti, J.A. Hammond, R.W. Gilbert
 
Vol 21, No 4 (2014) Role of neoadjuvant therapy in the management of pancreatic cancer: is the era of biomarkerdirected therapy here? Abstract   PDF   HTML
E.V. Tsvetkova, T.R. Asmis
 
Vol 19, No 1 (2012) Role of pemetrexed in advanced non-small-cell lung cancer: meta-analysis of randomized controlled trials, with histology subgroup analysis Abstract   PDF   HTML
K. Alsaleh, C. Quinton, P. M. Ellis
 
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective Role of surgery in high-risk localized prostate cancer Abstract   PDF
N. Lawrentschuk, G. Trottier, C. Kuk, A. R. Zlotta
 
Vol 18, No 5 (2011) Saccharin deemed “not hazardous” in United States and abroad Details   PDF   HTML
L.Z.G. Touyz
 
Vol 22, No 1 (2015) Safe handling of cytotoxics: guideline recommendations Abstract   PDF   HTML
A.C. Easty, N. Coakley, R. Cheng, M. Cividino, P. Savage, R. Tozer, R.E. White
 
1201 - 1300 of 1658 Items << < 8 9 10 11 12 13 14 15 16 17 > >>